The Journal of Minimally Invasive Gynecology
Volume 17, Issue 2 , Pages 161-166 , March 2010

Bilateral Oophorectomy versus Ovarian Conservation: Effects on Long-term Women's Health

  • William H. Parker, MD

      Affiliations

    • Corresponding Author InformationCorresponding author: William H. Parker, MD, John Wayne Cancer Institute at Saint John's Health Center, 1450 Tenth St., Santa Monica, CA 90401.

Received 23 September 2009 ,Accepted 24 December 2009.

References 

  1. Armstrong K, Schwartz J, Randall T, Rubin S, Weber B. Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis. J Clin Oncol. 2004;22:1045–1054
  2. Healthcare Cost and Utilization Project (HCUP), 1988-2001: A Federal-State-Industry Partnership in Health Data. July 2003. Agency for Healthcare Research and Quality, Rockville, MD. http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5105a1.htm
  3. Progetto Menopausa Italia Study Group 1. Determinants of hysterectomy and oophorectomy in women attending menopause clinics in Italy. Maturitas. 2000;36:19–25
  4. Judd H, Judd G, Lucas W, Yen S. Endocrine function of the postmentopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinl Metab. 1974;39:1020–1024
  5. Fogle R, Stanczyk F, Zhang X, Paulson R. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab. 2007;92:3040–3043
  6. Meldrum D, Davidson B, Tataryn I, Judd H. Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol. 1981;57:624–628
  7. Colditz G, Willett W, Stampfer M, Rosner B, Speizer F, Hennekens C. Menopause and the risk of coronary heart disease in women. N Engl J Med. 1987;316:1105–1110
  8. Ohta H, Makitab K, Komukaib S, Nozawab S. Bone resorption versus estrogen loss following oophorectomy and menopause. Maturitas. 2002;43:27–33
  9. Rocca W, Bower J, Maraganore D, Ahlskog J, Grossardt B, de Andrade M, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology. 2007;69:1074–1083
  10. Rocca W, Bower JH, Maraganore D, Ahlskog J, Grossardt B, de Andrade M, et al. Increased risk of parkinsonism in women who underwent oophorectomy before menopause. Neurology. 2008;70:200–209
  11. Rocca W, Grossardt B, Geda Y, Gostout B, Bower J, Maraganore D, et al. Long-term risk of depressive and anxiety symptoms after early bilateral oophorectomy. Menopause. 2008;15:1050–1059
  12. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96
  13. Hartge P, Whittemore AS, Itnyre J, McGowan L, Cramer D. Rates and risks of ovarian cancer in subgroups of white women in the United States: The Collaborative Ovarian Cancer Group. Obstet Gynecol. 1994;84:760–764
  14. Naylor AC. Hysterectomy–analysis of 2901 personally performed procedures. S Afr Med J. 1984;65:242–245
  15. Christ JE, Lotze EC. The residual ovary syndrome. Obstet Gynecol. 1975;46:551–556
  16. Parker WH, Broder MS, Chang E, et al. Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses' Health Study. Obstet Gynecol. 2009;113:1027–1037
  17. Kreiger N, Sloan M, Cotterchio M, Kirsh V. The risk of breast cancer following reproductive surgery. Eur J Cancer. 1999;35:97–101
  18. Schairer C, Persson I, Falkeborn M, Naessen T, Troisi R, Brinton LA. Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer. 1997;70:150–154
  19. SEER Cancer Statistics Review 1975-2006, National Cancer Institute, http://seer.cancer.gov/csr/1975_2006/results_merged/sect_04_breast.pdf accessed 9/4/09.
  20. Koushik A, Parent M, Siemiatycki J. Characteristics of menstruation and pregnancy and the risk of lung cancer in women. Int J Cancer
  21. Dekel A. Eur J Obstet Gynecol Reprod Biol. 1996;68:159–164
  22. Bailey CL, Ueland FR, Land GL, DePriest PD, Gallion HH, Kryscio RJ, et al. The malignant potential of small cystic ovarian tumors in women over 50 years of age. Gynecol Oncol. 1998;69:3–7
  23. Parker W, Broder M, Liu Z, Shoupe D, Farquhar C, Berek J. Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol. 2005;106:219–226
  24. Rocca W, Grossardt B, de Andrade M, Malkasian G, Melton J. Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. Lancet Oncol. 2006;7:821–828
  25. Rivera C, Grossardt B, Rhodes D, Rocca W. Increased Mortality for Neurological and Mental Diseases following Early Bilateral Oophorectomy. Neuroepidemiology. 2009;33:32–40
  26. Van der Schouw Y, van der Graa Y, Steyerberg E, Eijkemans M, Banga J. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 1996;347:714–718
  27. Løkkegaarda E, Jovanovicb Z, Heitmannc B, Keidingb N, Ottesend B, Pedersend A. The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy. Maturitas. 2006;53:226–233
  28. de Kleijn MJJ, van der Schouw YT, Verbeek ALM, Peeters PHM, Banga J-D, van der Graaf Y. Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal American women. J Epidemiology. 2002;155:339–345
  29. Falkeborn M, Schairer C, Naessen T, Persson I. Risk of myocardial infarction after oophorectomy and hysterectomy. J Clin Epidemiol. 2000;53:832–837
  30. Jacoby VL, Grady D, Sawaya GF. Oophorectomy as a risk factor for coronary heart disease. Am J Obstet Gynecol. 2009;200:140
  31. Kreiger N, Kelsey J, Holford TR, O'Connor T. An epidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol. 1982;116:141–148
  32. Raisz RK, Wilta B, Artis A, Bowen A, Schwartz S, Trahiotis M, et al. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab. 1996;81:37–43
  33. Ohta H, Makitab K, Komukaib S, Nozawab S. Bone resorption versus estrogen loss following oophorectomy and menopause. Maturitas. 2002;43:27–33
  34. Melton J, Khosla S, Malkasian GD, Achenbach SJ, Oberg AL, Riggs BL. Fracture risk after bilateral oophorectomy in elderly women. J Bone Miner Res. 2003;18:900–905
  35. Kritz-Silverstein D, von Mühlen D, Barrett-Connor E. Hysterectomy and oophorectomy are unrelated to bone loss in older women. Maturitas. 2004;47:61–69
  36. Antoniucci DM, Sellmeyer DE, Cauley JA, Ensrud KE, Schneider JL, Vesco KK, et al. Study of Osteoporotic Fractures Research Group. Postmenopausal bilateral oophorectomy is not associated with increased fracture risk in older women. J Bone Miner Res. 2005;20:741–747
  37. Keene G, Parker M, Pryor G. Mortality and morbidity after hip fractures. BMJ. 1993;13:1248–1250
  38. Vestergaard P, Rejnmark L, Mosekilde L. Loss of life years after a hip fracture: Effects of age and sex. Acta Orthopaedica. 2009;80:525–530
  39. Benedetti MD, Maraganore DM, Bower JH, et al. Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study. Mov Disord. 2001;16:830–837
  40. Ragonese P, D'Amelio M, Salemi G, et al. Risk of Parkinson disease in women: effect of reproductive characteristics. Neurology. 2004;62:2010–2014
  41. Ascherio A, Chen H, Schwarzschild M, Zhang S, Colditz G, Speizer F. Caffeine, postmenopausal estrogen, and risk of Parkinson's disease. Neurology. 2003;60:790–795
  42. Nappi R, Sinforiani E, Mauri M, Bono G, Polatti F, Nappi G. Memory functioning at menopause: impact of age in ovariectomized women. Gynecol Obstet Invest. 1999;47:29–36
  43. Farrag A, Khedr E, Abdel-Aleem H, Rageh T. Effect of surgical menopause on cognitive functions. Demet Geriatr Cogn Disord. 2002;13:193–198
  44. Kritz-Silverstein D, Barrett-Connor E. Hysterectomy, oophorectomy, and cognitive function in older women. J Am Geriatr Soc. 2002;50:55–61
  45. Nathorst-Boos J, von Schoultz B, Carlstrom K. Elective ovarian removal and estrogen replacement therapy-effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol. 1993;14:283–293
  46. Nieman L. Management of surgically hypogonadal patients unable to take sex hormone replacement therapy. Endocrinol Metab Clin North Am. 2003;32:325–236
  47. Hansen K. Female reproductive biology. In:  O'Leary P,  Tabuenca A,  Capote LR editor. The physiologic basis of surgery. Philadelphia: Lippincott Williams and Wilkins; 2007;p. 314–315
  48. Shifren J. Androgen deficiency in the oophorectomized woman. Fertil Steril. 2002;77(Suppl 4):s60–s62
  49. Sherwin B, Gelfan M. the role of androgens in the maintenance of sexual functioning in oophorectomized women. Psychosom Med. 1978;49:397–409
  50. Gallicchio L, Whiteman MK, Tomic D, Miller KP, Langenberg P, Flaws JA. Type of menopause, patterns of hormone therapy use, and hot flashes. Fertil Steril. May, 2006;85:1432–1440
  51. Farrag A, Khedr E, Abdel-Aleem H, Rageh T. Effect of surgical menopause on cognitive functions. Demet Geriatr Cogn Disord. 2002;13:193–198
  52. Sherwin B. Surgical menopause, estrogen and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology. 1988;13:345–357
  53. Bachmann GA, Nevadunsky NS. Diagnosis and treatment of atrophic vaginitis. Am Fam Physician. 2000;61:3090–3096
  54. Lieblum S, Bachmann G, Kemmann E, Colburn D, Swartzman L. Vaginal atrophy in the postmenopausal woman. The importance of sexual activity and hormones. JAMA. 1983;249:2195–2198
  55. Schifren J, Braustein G, Simon J, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343:682–688
  56. Elit l, Esplen M, Butler K, Narod S . Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. Familial Cancer. 2001;1:149–156
  57. Sherwin BB, Gelfan MM. the role of androgens in the maintenance of sexual functioning in oophorectomized women. Psychosom Med. 1978;49:397–409
  58. Teplin V, Vittinghoff E, Lin F, Learman L, Richter H, Kuppermann M. Oophorectomy in premenopausal women: health-related quality of life and sexual functioning. Obstet Gynecol. 2007;109:347–354
  59. Wegienka G, Havstad S, Kelsey J. Menopausal hormone therapy in a health maintenance organization before and after Women's Health Initiative hormone trials termination. J Women's Health. 2006;15:369–378

 The author does not have any conflicts of interest or financial disclosures.

PII: S1553-4650(09)01345-4

doi: 10.1016/j.jmig.2009.12.016

The Journal of Minimally Invasive Gynecology
Volume 17, Issue 2 , Pages 161-166 , March 2010

Article Tools